SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$33.03
+$0.79 (+2.45%)
Nov 2, 2026, 9:55 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 |
|---|---|---|---|---|
Net Income | -19.86M | -13.82M | -12.56M | -9.82M |
Depreciation & Amortization | 341K | 318K | 216.73K | 137.27K |
Stock-Based Compensation | n/a | n/a | 922.25K | 931.75K |
Other Working Capital | 1.74M | -2.48M | 1.55M | 994.29K |
Other Non-Cash Items | 2.21M | 1.71M | -478.87K | 70.87K |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.48M | -1.75M | 2.56M | -164.95K |
Operating Cash Flow | -14.84M | -13.54M | -9.33M | -8.84M |
Capital Expenditures | -1.93M | -676K | -420.49K | -152.51K |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | -7M | -4M | -5M | -12M |
Sales Maturities Of Investments | 8M | 3.01M | 6M | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | -933K | -1.67M | 574.7K | -12.15M |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -909.77K | -273.23K |
Financial Cash Flow | 13K | 157.76M | -889.64K | -234.36K |
Net Cash Flow | -15.76M | 142.54M | -9.65M | -21.23M |
Free Cash Flow | -16.77M | -14.22M | -9.75M | -8.99M |
Adj. Free Cash Flow | -16.77M | -14.22M | -10.68M | -9.93M |
Maintenance CapEx | -341K | -318K | -216.73K | -137.27K |
Growth CapEx | -1.59M | -358K | -203.77K | -15.23K |
Owner Earnings | -15.18M | -13.86M | -9.55M | -8.98M |
Add to Watchlist
Select watchlists to add or remove SGP